Valiant Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,860	1,334	1,821	3,339	3,124
Revenue Growth (YoY)	66.91%	-26.74%	-45.48%	6.90%	-
Cost of Revenue	1,574	1,170	1,705	2,789	2,530
Gross Profit	285.94	163.9	115.76	549.82	594.07
Selling, General & Admin	47.26	43.88	43.13	46.13	33.44
Other Operating Expenses	169.4	166.81	156.71	152.79	101.43
Operating Expenses	237.71	231.62	219.49	214.55	159.13
Operating Income	48.24	-67.72	-103.73	335.28	434.94
Interest Expense	-3.24	-1.74	-0.78	-2.54	-0.36
Interest & Investment Income	30.27	30.27	26.77	0.97	8.31
Currency Exchange Gain (Loss)	-0.15	-0.15	2.89	5.83	8.72
Other Non Operating Income (Expenses)	-27.02	19.48	58.74	3.45	1.05
EBT Excluding Unusual Items	48.09	-19.86	-16.11	342.99	452.66
Gain (Loss) on Sale of Investments	4.73	4.73	8.42	38.37	-
Pretax Income	52.83	-15.13	-7.7	381.36	452.66
Income Tax Expense	2.13	6.89	-10.89	91.38	111.93
Net Income	50.7	-22.01	3.2	289.98	340.74
Net Income to Common	50.7	-22.01	3.2	289.98	340.74
Net Income Growth	-	-	-98.90%	-14.89%	-
Shares Outstanding (Basic)	43	43	38	33	33
Shares Outstanding (Diluted)	43	43	38	33	33
Shares Change (YoY)	0.06%	14.33%	16.72%	-	-
EPS (Basic)	1.17	-0.51	0.08	8.91	10.46
EPS (Diluted)	1.16	-0.51	0.08	8.91	10.46
EPS Growth	-	-	-99.06%	-14.88%	-
Free Cash Flow	-781.1	-1,125	-439.85	183.7	49.48
Free Cash Flow Per Share	-17.98	-25.90	-11.57	5.64	1.52
Gross Margin	15.37%	12.29%	6.36%	16.47%	19.02%
Operating Margin	2.59%	-5.08%	-5.70%	10.04%	13.92%
Profit Margin	2.73%	-1.65%	0.18%	8.68%	10.91%
Free Cash Flow Margin	-41.98%	-84.37%	-24.16%	5.50%	1.58%
EBITDA	67.37	-48.7	-85.98	349.23	456.55
EBITDA Margin	3.62%	-3.65%	-4.72%	10.46%	14.62%
D&A For EBITDA	19.14	19.02	17.75	13.95	21.61
EBIT	48.24	-67.72	-103.73	335.28	434.94
EBIT Margin	2.59%	-5.08%	-5.70%	10.04%	13.92%
Effective Tax Rate	4.03%	-	-	23.96%	24.73%
Revenue as Reported	1,868	1,388	1,917	3,388	3,149

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.